back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-07-03 16:18 Tx date 2025-06-30 |
$BHC
Bausch Health Companies Inc. |
Icahn, Brett
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+4,034 vol |
219,536 | |
| Filed 2025-05-28 16:22 Tx date 2025-05-27 |
$BLCO
Bausch + Lomb Corporation |
Icahn, Brett
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+20,338 vol |
20,338 | |
| Filed 2025-05-21 15:38 Tx date 2025-05-20 |
$BLCO
Bausch + Lomb Corporation |
Icahn, Brett
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$172,678
+14,696 vol $11.75 each |
40,809 | |
| Filed 2025-05-21 15:37 Tx date 2025-05-20 |
$BLCO
Bausch + Lomb Corporation |
Icahn, Brett
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
$-172,678
-14,696 vol $11.75 each |
0 | |
| Filed 2025-05-20 14:38 Tx date 2025-05-16 |
$BHC
Bausch Health Companies Inc. |
Icahn, Brett
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,996
+54,347 vol $4.60 each |
215,502 | |
| Filed 2025-04-01 17:22 Tx date 2025-03-31 |
$BHC
Bausch Health Companies Inc. |
Icahn, Brett
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$33,119
+5,119 vol $6.47 each |
161,155 | |
| Filed 2025-01-02 11:25 Tx date 2024-12-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$33,118
+4,109 vol $8.06 each |
156,036 | |
| Filed 2024-10-01 17:42 Tx date 2024-09-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$33,121
+4,059 vol $8.16 each |
151,927 | |
| Filed 2024-08-06 21:54 Tx date 2024-08-02 |
$BLCO
Bausch + Lomb Corporation |
Icahn, Brett
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+14,696 vol |
14,696 | |
| Filed 2024-07-02 14:40 Tx date 2024-06-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$33,121
+4,752 vol $6.97 each |
147,868 | |
| Filed 2024-05-30 11:39 Tx date 2024-05-28 |
$BLCO
Bausch + Lomb Corporation |
Icahn, Brett
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$193,112
+12,857 vol $15.02 each |
26,113 | |
| Filed 2024-05-30 11:39 Tx date 2024-05-28 |
$BLCO
Bausch + Lomb Corporation |
Icahn, Brett
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
$-193,112.14
-12,857 vol $15.02 each |
0 | |
| Filed 2024-05-21 17:01 Tx date 2024-05-17 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,995
+35,360 vol $7.07 each |
143,116 | |
| Filed 2024-04-01 17:33 Tx date 2024-03-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+3,122 vol |
107,756 | |
| Filed 2024-01-02 17:24 Tx date 2023-12-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$33,122
+4,130 vol $8.02 each |
104,634 | |
| Filed 2024-01-02 17:22 Tx date 2023-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$29,840
+3,684 vol $8.10 each |
63,130 | |
| Filed 2023-04-05 12:36 Tx date 2023-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$29,840
+3,684 vol $8.10 each |
||
| Filed 2023-10-03 11:42 Tx date 2023-09-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$33,118
+4,029 vol $8.22 each |
100,504 | |
| Filed 2023-07-04 16:54 Tx date 2023-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$33,120
+4,140 vol $8.00 each |
96,475 | |
| Filed 2023-05-23 12:44 Tx date 2023-05-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,994
+29,205 vol $8.56 each |
92,335 | |
| Filed 2023-05-08 10:02 Tx date 2023-05-04 |
$BLCO
Bausch + Lomb Corporation |
Icahn, Brett
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+12,857 vol |
12,857 | |
| Filed 2023-04-27 16:56 Tx date 2023-04-24 |
$BLCO
Bausch + Lomb Corporation |
Icahn, Brett
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$226,942
+13,256 vol $17.12 each |
13,256 | |
| Filed 2023-04-27 16:56 Tx date 2022-06-21 |
$BLCO
Bausch + Lomb Corporation |
Icahn, Brett
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-04-27 16:55 Tx date 2023-04-24 |
$BLCO
Bausch + Lomb Corporation |
Icahn, Brett
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
$-226,942.72
-13,256 vol $17.12 each |
0 | |
| Filed 2023-04-05 12:36 Tx date 2023-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$29,840
+3,684 vol $8.10 each |
63,130 | |
| Filed 2023-01-04 16:59 Tx date 2022-12-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$28,818
+4,589 vol $6.28 each |
59,446 | |
| Filed 2022-10-04 16:31 Tx date 2022-09-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$30,619
+4,444 vol $6.89 each |
54,857 | |
| Filed 2022-07-06 14:58 Tx date 2022-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$30,622
+3,663 vol $8.36 each |
50,413 | |
| Filed 2022-07-06 13:49 Tx date 2022-06-28 |
$BLCO
Bausch + Lomb Corporation |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+13,256 vol |
13,256 | |
| Filed 2022-07-06 13:48 Tx date 2022-06-21 |
$BLCO
Bausch + Lomb Corporation |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-06-29 12:52 Tx date 2022-06-24 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+34,387 vol |
46,750 | |
| Filed 2022-04-05 12:05 Tx date 2022-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$30,619
+1,340 vol $22.85 each |
12,363 | |
| Filed 2022-01-04 12:50 Tx date 2021-12-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+1,109 vol |
11,023 | |
| Filed 2021-10-04 18:18 Tx date 2021-09-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$30,607
+1,099 vol $27.85 each |
9,914 | |
| Filed 2021-07-05 11:20 Tx date 2021-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$30,610
+1,044 vol $29.32 each |
8,815 | |
| Filed 2021-05-03 19:41 Tx date 2021-04-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,991
+7,645 vol $32.70 each |
7,771 | |
| Filed 2021-04-30 17:44 Tx date 2021-04-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$23,250
+744 vol $31.25 each |
744 | |
| Filed 2021-04-30 17:44 Tx date 2021-04-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-744 vol |
126 | |
| Filed 2021-04-05 13:04 Tx date 2021-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$3,999
+126 vol $31.74 each |
870 | |
| Filed 2021-03-24 17:59 Tx date 2021-03-17 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-24 17:54 Tx date 2021-03-22 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$24,552
+744 vol $33.00 each |
744 | |
| Filed 2021-03-24 17:50 Tx date 2021-03-17 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|